Biocryst Pharmaceuticals buy Evercore Inc.
Start price
18.02.26
/
50%
€6.00
Target price
18.02.27
€14.35
Performance (%)
26.77%
Price
15:32
€7.61
Summary
This prediction is currently active. The BUY prediction by Evercore_Inc_ currently has a performance of 26.77%. This prediction currently runs until 18.02.27. The prediction end date can be changed by Evercore_Inc_ at any time. Evercore_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -7.040% | -7.040% |
| iShares Core DAX® | -1,74 % | 5,67 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % |
| iShares S&P 500 | 0,97 % | 7,24 % |
Comments by Evercore_Inc_ for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat